Anna McNaughton
PhD
Postdoctoral Scientist
I am a postdoctoral researcher in the Matthews Group working on hepatitis B virus (HBV), with a focus on populations in Southern Africa. I am working on the development of deep sequencing pipelines for whole genome sequencing of HBV, using both Illumina and Nanopore platforms.
My research interests span a number of fields including the development of viral sequencing methods, blood-borne viral infections, pathogen transmission, viral diversity and evolution, as well as international health and infectious disease epidemiology.
Prior to working at Oxford, I studied at the University of Bristol, the London School of Hygiene and Tropical Medicine, and I undertook my PhD studies on hepatitis C virus (HCV) at the MRC Centre for Virus Research at the University of Glasgow.
Key publications
-
Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis
Journal article
McNaughton AL. et al, (2020), PLOS Medicine, 17, e1003068 - e1003068
-
HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model
Journal article
McNaughton AL. et al, (2019), BMC Medicine, 17
-
Rolling circle amplification and nanopore-based deep sequencing of full-length HBV genomes
Conference paper
Mcnaughton A. et al, (2018), Journal of Hepatology, 68, S762 - S762
-
Insights From Deep Sequencing of the HBV Genome—Unique, Tiny, and Misunderstood
Journal article
McNaughton AL. et al, (2019), Gastroenterology, 156, 384 - 399
-
Hepatitis B Virus Infection as a Neglected Tropical Disease
Journal article
O'Hara G. et al, (2017)
-
Spatiotemporal Reconstruction of the Introduction of Hepatitis C Virus into Scotland and Its Subsequent Regional Transmission.
Journal article
McNaughton AL. et al, (2015), J Virol, 89, 11223 - 11232
Recent publications
-
Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?
Journal article
Pley C. et al, (2022), Journal of Virology
-
Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
Journal article
Wang T. et al, (2021), BMC Infectious Diseases, 21
-
Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients.
Journal article
Youngs J. et al, (2021), PLoS Pathog, 17
-
Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection
Journal article
Downs LO. et al, (2021), Wellcome Open Research, 5, 240 - 240
-
The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
Journal article
Pley CM. et al, (2021), BMJ Global Health, 6, e004275 - e004275